---
document_datetime: 2023-09-21 19:14:38
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/iasibon-epar-all-authorised-presentations_en.pdf
document_name: iasibon-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.4275743
conversion_datetime: 2025-12-27 23:45:43.752364
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Name    | Strength   | Pharmaceutical Form                   | Route of Administration   | Packaging                                          | Content (concentration)   | Package size   |
|-----------------|---------|------------|---------------------------------------|---------------------------|----------------------------------------------------|---------------------------|----------------|
| EU/1/10/659/001 | Iasibon | 50 mg      | Film-coated tablet                    | Oral use                  | blister (PA/ALL/PVC/alu)                           |                           | 28 tablets     |
| EU/1/10/659/002 | Iasibon | 50 mg      | Film-coated tablet                    | Oral use                  | blister (PA/ALL/PVC/alu)                           |                           | 84 tablets     |
| EU/1/10/659/003 | Iasibon | 1 mg       | Concentrate for solution for infusion | Intravenous use           | ampoule (glass)                                    | 1ml (1 mg/1 ml)           | 1 ampoule      |
| EU/1/10/659/004 | Iasibon | 2 mg       | Concentrate for solution for infusion | Intravenous use           | ampoule (glass)                                    | 2 ml (2 mg/2 ml)          | 1 ampoule      |
| EU/1/10/659/005 | Iasibon | 6 mg       | Concentrate for solution for infusion | Intravenous use           | vial (glass) closed by red elastic rubber stoppers | 6 ml (6 mg/6 ml)          | 1 vial         |
| EU/1/10/659/006 | Iasibon | 6 mg       | Concentrate for solution for infusion | Intravenous use           | vial (glass) closed by red elastic rubber stoppers | 6 ml (6 mg/6 ml)          | 5 vials        |
| EU/1/10/659/007 | Iasibon | 6 mg       | Concentrate for solution for infusion | Intravenous use           | vial (glass) closed by red elastic rubber stoppers | 6 ml (6 mg/6 ml)          | 10 vials       |
| EU/1/10/659/008 | Iasibon | 50 mg      | Film-coated tablet                    | Oral use                  | blister (PA/ALL/PVC/alu)                           |                           | 3 tablets      |
| EU/1/10/659/009 | Iasibon | 50 mg      | Film-coated tablet                    | Oral use                  | blister (PA/ALL/PVC/alu)                           |                           | 6 tablets      |
| EU/1/10/659/010 | Iasibon | 50 mg      | Film-coated tablet                    | Oral use                  | blister (PA/ALL/PVC/alu)                           |                           | 9 tablets      |